Vaccines

• 

  Subject Areas on Research

  • 10-year research update review: the epidemiology of child and adolescent psychiatric disorders: II. Developmental epidemiology. 
  • A New Vaccine to Battle Covid-19. 
  • A need for effective adjuvants. 
  • A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. 
  • Active immunotherapy with transiently transfected cytokine-secreting tumor cells inhibits breast cancer metastases in tumor-bearing animals. 
  • Addressing the vaccine confidence gap. 
  • Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health. 
  • Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older - United States, 2014. 
  • Analysis of human innate immune responses to PRINT fabricated nanoparticles with cross validation using a humanized mouse model. 
  • Anti-idiotypic antibodies as vaccine candidates. The immune network. 
  • Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell-mediated cytotoxicity assay. 
  • Arthroscopic surgical management of shoulder secondary to shoulder injury related to vaccine administration (SIRVA): a case report. 
  • Association of vaccine-related attitudes and beliefs between parents and health care providers 
  • B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. 
  • Biomaterial strategies for generating therapeutic immune responses. 
  • Broadly Neutralizing Antibodies and the Development of Vaccines. 
  • Buyer beware: The risks of donor-derived vaccine-induced thrombosis and thrombocytopenia. 
  • Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021. 
  • Cellular immune responses in neonates. 
  • Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration. 
  • Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain. 
  • Chemistry. Nanomaterials for drug delivery. 
  • Childhood immunization programs: an analysis of policy issues. 
  • Closing the global vaccine equity gap: equitably distributed manufacturing. 
  • Coming together at the hinges: Therapeutic prospects of IgG3. 
  • Commentary: Vaccines-Protecting Health and Saving Lives. 
  • Comparing data mining methods on the VAERS database. 
  • Comparison of multiple vaccine vectors in a single heterologous prime-boost trial. 
  • Controversies in immunization. 
  • Cysteine-tailed class I-binding peptides bind to CpG adjuvant and enhance primary CTL responses. 
  • Cytokines: the future of intranasal vaccine adjuvants. 
  • Demographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010-2020. 
  • Design of an Escherichia coli expressed HIV-1 gp120 fragment immunogen that binds to b12 and induces broad and potent neutralizing antibodies. 
  • Determinants and Trends of COVID-19 Vaccine Hesitancy and Vaccine Uptake in a National Cohort of US Adults: A Longitudinal Study. 
  • Development and application of a multiplex assay for the simultaneous measurement of antibody responses elicited by common childhood vaccines. 
  • Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials. 
  • Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents? 
  • Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery. 
  • Effect of antipyretic analgesics on immune responses to vaccination. 
  • Effect of endotoxin and alum adjuvant vaccine on peanut allergy. 
  • Engineering challenges for brain tumor immunotherapy 
  • Enhanced dendritic cell antigen presentation in RNA-based immunotherapy. 
  • Evaluating associations between vaccine response and malnutrition, gut function, and enteric infections in the MAL-ED cohort study: methods and challenges. 
  • Eye-tracking evidence shows that non-fit messaging impacts attention, attitudes and choice. 
  • Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies. 
  • Future trends in managing hepatitis C. 
  • Future vaccines and a global perspective. 
  • Generation of Tumor Targeted Dendritic Cell Vaccines with Improved Immunogenic and Migratory Phenotype. 
  • Global progress in the control of diarrheal diseases. 
  • Gradated assembly of multiple proteins into supramolecular nanomaterials. 
  • Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. 
  • Guidelines for immunizations in patients with inflammatory bowel disease. 
  • HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design. 
  • Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity. 
  • History Lesson: Vaccine Trials in the Classroom. 
  • Ideal Vaccines: Balancing B Cell Recruitment and Differentiation. 
  • Immunization and MS: a summary of published evidence and recommendations. 
  • Immunosenescence of ageing. 
  • Immunotherapy of cancer using cytokine gene-modified tumor vaccines. 
  • Infections in Pregnancy and the Role of Vaccines. 
  • Maternal benefits of immunization during pregnancy. 
  • Maternal immunization: opportunities for scientific advancement. 
  • Mercury Exposure and Poor Nutritional Status Reduce Response to Six Expanded Program on Immunization Vaccines in Children: An Observational Cohort Study of Communities Affected by Gold Mining in the Peruvian Amazon. 
  • Mercury, vaccines, and autism: one controversy, three histories. 
  • Modular complement assemblies for mitigating inflammatory conditions. 
  • Modulating atherothrombosis: is there a place for vaccines in global prevention strategies? 
  • Monocytes as a Cellular Vaccine Platform to Induce Antitumor Immunity. 
  • Mucosal immunity to infection with implications for vaccine development. 
  • Mucosal vaccine development for botulinum intoxication. 
  • Mucosal vaccine targeting improves onset of mucosal and systemic immunity to botulinum neurotoxin A. 
  • New findings on nicotine addiction and treatment. 
  • No Shot: US Vaccine Prices And Shortages. 
  • Non-reassuring fetal status: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. 
  • Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8(+) T cell population in different tissues. 
  • Nucleic acid aptamers as adjuncts to vaccine development. 
  • Paired Toll-like receptor agonists enhance vaccine therapy through induction of interleukin-12. 
  • Parental vaccine refusal in Wisconsin: a case-control study. 
  • Polymer hydrogels: Chaperoning vaccines. 
  • Presidential address. Reflections on the 1970s and a look to the future. 
  • Priming, boosting, measuring. 
  • Principles of Anti-infective Dosing in Pregnancy. 
  • Promoting Vaccine Confidence. 
  • Reply to Gantt et al., "Higher Expectations for a Vaccine To Prevent Congenital Cytomegalovirus Infection". 
  • Research on vaccines during pregnancy: protocol design and assessment of safety. 
  • Research on vaccines during pregnancy: reference values for vital signs and laboratory assessments. 
  • Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV. 
  • Softness makes it better. 
  • Some state vaccination laws contribute to greater exemption rates and disease outbreaks in the United States. 
  • Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration. 
  • The HIV-positive traveler. 
  • The Impact of the Gut Microbiota on Humoral Immunity to Pathogens and Vaccination in Early Infancy. 
  • The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success. 
  • The challenges of checkpoint inhibition in the treatment of multiple myeloma. 
  • The fragility of the U.S. vaccine supply. 
  • The limits of refusal: An ethical review of solid organ transplantation and vaccine hesitancy. 
  • The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia. 
  • Therapeutic vaccines for aggressive B-cell lymphoma. 
  • Titrating T-cell epitopes within self-assembled vaccines optimizes CD4+ helper T cell and antibody outputs. 
  • Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity. 
  • UK announces cash boost for vaccines and free health care in poor countries. 
  • Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques. 
  • Update on immunizations in adults. 
  • Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes. 
  • Vaccinations for pregnant women. 
  • Vaccine Development: Steps to Approval of an Investigational Vaccine. 
  • Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates. 
  • Vaccine Hesitancy in North Carolina: The Elephant in the Room? 
  • Vaccine Hesitancy in Rural Pediatric Primary Care. 
  • Vaccine coverage and adherence to EPI schedules in eight resource poor settings in the MAL-ED cohort study. 
  • Vaccine innovations for emerging infectious diseases-a symposium report. 
  • Vaccine knowledge and practices of primary care providers of exempt vs. vaccinated children 
  • Vaccine safety: medical contraindications, myths, and risk communication. 
  • Vaccine storage practices in primary care physician offices: assessment and intervention. 
  • Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways. 
  • Vaccine-preventable diseases in pregnancy. 
  • [Emerging adenovirus threats: should China develop a vaccine-oriented prevention strategy?]. 
• 

  Keywords of People

  • Gromeier, Matthias, Professor of Neurosurgery, Molecular Genetics and Microbiology
  • Johnson-Weaver, Brandi, Research Scientist, Senior, Pathology
  • Kelsoe, Garnett H., James B. Duke Distinguished Professor of Immunology, Immunology
  • Lee, Walter T, Professor of Head and Neck Surgery & Communication Sciences, Radiation Oncology
  • Moody, Michael Anthony, Professor of Pediatrics, Immunology
  • Vasudevan, Lavanya, Assistant Professor in Family Medicine and Community Health, Family Medicine and Community Health